Evidence map›Paper›PMID 32326381›Full record

ArticleInternational journal of molecular sciences2020

Obesity-Altered Adipose Stem Cells Promote Radiation Resistance of Estrogen Receptor Positive Breast Cancer through Paracrine Signaling.

Rachel A Sabol, Vidal A Villela, Alexandra Denys, Benjamin T Freeman, Alifiani B Hartono, Rachel M Wise, Mark A A Harrison, Maxwell B Sandler, Fokhrul Hossain, Lucio Miele and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Rachel A SabolCenter for Stem Cell Research, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Vidal A VillelaCenter for Stem Cell Research, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Alexandra DenysCenter for Stem Cell Research, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Benjamin T FreemanDepartment of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA 70112, USA.
Alifiani B HartonoPathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Rachel M WiseCenter for Stem Cell Research, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Mark A A HarrisonCenter for Stem Cell Research, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0003-4685-3757
Maxwell B SandlerCenter for Stem Cell Research, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Fokhrul HossainLouisiana State University Health Sciences Center (LSUHSC), Department of Genetics, New Orleans, LA 70112, USA.
Lucio MieleLouisiana State University Health Sciences Center (LSUHSC), Department of Genetics, New Orleans, LA 70112, USA.
Bruce A BunnellCenter for Stem Cell Research, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0001-6196-3722
Tulane University · USLouisiana Cancer Research Center · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
UAB Center for Clinical and Translational Sciences (CCTS)TL1TR001418 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2015 to 2018
$2.1M
NCATS NIH HHS TL1TR001418NIGMS NIH HHS U54 GM104940undefined <span style="color:gray;font-size:10px;">undefined</span> OD11104
6 · The paper itself

Abstract

Obesity is associated with poorer responses to chemo- and radiation therapy for breast cancer, which leads to higher mortality rates for obese women who develop breast cancer. Adipose stem cells (ASCs) are an integral stromal component of the tumor microenvironment (TME). In this study, the effects of obesity-altered ASCs (obASCs) on estrogen receptor positive breast cancer cell's (ER

Indexed as

Adipose TissueAnimalsApoptosisBreast NeoplasmsCell ProliferationCell SurvivalCoculture TechniquesDNA DamageFemaleGene Knockdown TechniquesHumansInterleukin-6LeptinMCF-7 CellsMesenchymal Stem CellsMiceIL6 protein, humanInterleukin-6LeptinReceptors, EstrogenReceptors, NotchRNA, Small Interferingadipose stem cellsbreast cancerobesityradiation resistanceradiotherapy

Identifiers

PMID32326381
PMCPMC7216284
OpenAlexW3016533251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.